{"transactions":[{"id":2999031,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"EVP of Sales & Marketing"}}],"security":"Warrant (right to buy)","published_at":"2020-10-28T20:45:11.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":14422,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025."}],"balance_after":689422,"derivative":{"exercise_price":0.57,"exercise_date":"2020-10-22","expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":14422},"source":{"system":"sec-edgar","filing":"0001437749-20-021859","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021859/rdgdoc.xml","form_type":"4"}},{"id":2999030,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"EVP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2020-10-28T20:45:11.000Z","date":"2020-10-22","kind":"purchase","acquired":true,"shares":28844,"price":0.52,"value":14998.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Purchased pursuant to public offering that closed on October 22, 2020."}],"balance_after":83844,"source":{"system":"sec-edgar","filing":"0001437749-20-021859","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920021859/rdgdoc.xml","form_type":"4"}},{"id":3100374,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"EVP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2020-06-25T20:48:42.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/23/2020, and the remaining 75% will vest over the next three (3) years, commencing on 6/23/2021, until fully vested."}],"balance_after":675000,"derivative":{"exercise_price":0.61,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-20-013880","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774920013880/rdgdoc.xml","form_type":"4"}},{"id":3363681,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common stock","published_at":"2019-11-21T21:30:27.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":50000,"price":0.3899,"value":19495.0,"ownership":{"direct":false,"nature":"These shares are beneficially owned in an IRA for the benefit of the Reporting Person."},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001437749-19-023360","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919023360/rdgdoc.xml","form_type":"4"}},{"id":3480718,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2019-06-24T20:58:33.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/18/2019, and the remaining 75% will vest over the next three (3) years, commencing on 6/18/2020, until fully vested."}],"balance_after":525000,"derivative":{"exercise_price":0.43,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-19-012559","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774919012559/rdgdoc.xml","form_type":"4"}},{"id":3887700,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2018-06-20T20:14:43.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% vested as of 6/13/2018, and the remaining 75% will vest over the next three (3) years, commencing on 6/13/2019, until fully vested."}],"balance_after":375000,"derivative":{"exercise_price":0.46,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-18-012130","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774918012130/rdgdoc.xml","form_type":"4"}},{"id":4155645,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":3900,"price":0.48,"value":1872.0,"ownership":{"direct":true},"balance_after":55000,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155644,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":100,"price":0.48,"value":48.0,"ownership":{"direct":true},"balance_after":51100,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155643,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":200,"price":0.47,"value":94.0,"ownership":{"direct":true},"balance_after":51000,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155642,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":200,"price":0.48,"value":96.0,"ownership":{"direct":true},"balance_after":50800,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155641,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":40,"price":0.49,"value":19.6,"ownership":{"direct":true},"balance_after":50600,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155640,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":300,"price":0.47,"value":141.0,"ownership":{"direct":true},"balance_after":50560,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155639,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":10160,"price":0.5,"value":5080.0,"ownership":{"direct":true},"balance_after":50260,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155638,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":200,"price":0.46,"value":92.0,"ownership":{"direct":true},"balance_after":40100,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155637,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":500,"price":0.47,"value":235.0,"ownership":{"direct":true},"balance_after":39900,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155636,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":126,"price":0.47,"value":59.22,"ownership":{"direct":true},"balance_after":39400,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155635,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":1400,"price":0.5,"value":700.0,"ownership":{"direct":true},"balance_after":39274,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155634,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":700,"price":0.5,"value":350.0,"ownership":{"direct":true},"balance_after":37874,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155633,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":10600,"price":0.5,"value":5300.0,"ownership":{"direct":true},"balance_after":37174,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155632,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":6965,"price":0.5,"value":3482.5,"ownership":{"direct":true},"balance_after":26574,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4155631,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"officer":true,"officer_title":"VP of Sales & Marketing"}}],"security":"Common Stock","published_at":"2017-11-21T21:07:13.000Z","date":"2017-11-20","kind":"purchase","acquired":true,"shares":19609,"price":0.5,"value":9804.5,"ownership":{"direct":true},"balance_after":19609,"source":{"system":"sec-edgar","filing":"0001437749-17-019679","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000143774917019679/rdgdoc.xml","form_type":"4"}},{"id":4270754,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-30T01:14:14.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved a termination of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.605,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001642247-17-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000017/primary_doc.xml","form_type":"4/A","original_submission_date":"2017-06-29"}},{"id":4270753,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-30T01:14:14.000Z","date":"2017-06-15","kind":"disposition_to_issuer","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two reported transactions involved a termination of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two reported transactions involved a termination of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a new option."}],"balance_after":0,"derivative":{"exercise_price":0.83,"expiration_date":"2026-03-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001642247-17-000017","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000017/primary_doc.xml","form_type":"4/A","original_submission_date":"2017-06-29"}},{"id":4270742,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-29T21:11:06.000Z","date":"2017-06-27","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two transactions involved a termination of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% vested as of 6/27/2017, and the remaining 75% will vest over the next three (3) years, commencing on 6/27/2018, until fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.605,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001642247-17-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000010/primary_doc.xml","form_type":"4"}},{"id":4270741,"issuer":{"id":694,"kind":"organization","name":"Perspective Therapeutics, Inc.","symbol":"CATX"},"owners":[{"id":145704,"kind":"person","name":"Krachon Michael","position":1,"cik":"0001677655","reported_name":"Krachon Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP of Sales & Marketing"}}],"security":"Stock Options (right to buy)","published_at":"2017-06-29T21:11:06.000Z","date":"2017-06-15","kind":"disposition_to_issuer","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The two transactions involved a termination of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a new option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The two transactions involved a termination of an outstanding option, resulting in the deemed cancellation of the old option and the grant of a new option."}],"balance_after":0,"derivative":{"exercise_price":0.83,"expiration_date":"2026-03-07","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001642247-17-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/728387/000164224717000010/primary_doc.xml","form_type":"4"}}]}